Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Seelos Therapeutics (SEEL) just unveiled an update.
Seelos Therapeutics, Inc. has announced an upcoming reverse split of its common stock, aiming to make a strategic move in the market. This decision is detailed in their latest press release, which investors might find of significant interest, as it could affect stock value and ownership.
For a thorough assessment of SEEL stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue